{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:21:55Z","timestamp":1793823715977,"version":"4.6.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.athplu.2023.08.001","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T04:14:16Z","timestamp":1692418456000},"page":"33-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["High-density lipoproteins and non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7463-2893","authenticated-orcid":false,"given":"Menno","family":"Hoekstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Van Eck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.athplu.2023.08.001_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.athplu.2023.08.001_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41366-021-01015-w","article-title":"Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank","volume":"46","author":"De Vincentis","year":"2022","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13695","article-title":"Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis","volume":"52","author":"Guerra","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"10.1016\/j.athplu.2023.08.001_bib5","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","article-title":"Genetics of NAFLD in twins consortium. Heritability of hepatic fibrosis and steatosis based on a prospective twin study","volume":"149","author":"Loomba","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jcmgh.2021.11.007","article-title":"TM6SF2\/PNPLA3\/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models","volume":"13","author":"Longo","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jhep.2022.03.031","article-title":"EPIDEMIC Study Investigators. Rare ATG7 genetic variants predispose patients to severe fatty liver disease","volume":"77","author":"Baselli","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","article-title":"Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease","volume":"76","author":"Luukkonen","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.athplu.2023.08.001_bib9","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3350\/cmh.2021.0406","article-title":"Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals","volume":"28","author":"Tang","year":"2022","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib11","first-page":"196","article-title":"Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis","volume":"16","author":"Koulaouzidis","year":"2021","journal-title":"Przeglad Gastroenterol"},{"issue":"6","key":"10.1016\/j.athplu.2023.08.001_bib12","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Alon","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.athplu.2023.08.001_bib13","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.athplu.2023.08.001_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metabol"},{"key":"10.1016\/j.athplu.2023.08.001_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110733","article-title":"Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease","volume":"201","author":"Chen","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.athplu.2023.08.001_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/liv.15556","article-title":"Fatty liver disease, heart rate and cardiac remodelling: evidence from the UK Biobank","volume":"43","author":"Jamialahmadi","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.athplu.2023.08.001_bib18","article-title":"The monocyte-to-high-density lipoprotein ratio is associated with the occurrence of atrial fibrillation among NAFLD patients: a propensity-matched analysis","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.mol.0000169351.28019.04","article-title":"Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis","volume":"16","author":"Van Eck","year":"2005","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.athplu.2023.08.001_bib20","article-title":"HDL maturation and remodelling","volume":"1867","author":"Ong","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12876-021-01974-4","article-title":"The liver steatosis severity and lipid characteristics in primary biliary cholangitis","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12944-019-0984-9","article-title":"Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study","volume":"18","author":"Ren","year":"2019","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.athplu.2023.08.001_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis","volume":"227","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.athplu.2023.08.001_bib24","first-page":"439","article-title":"MONOCYTE\/HDL ratio in non-alcoholic hepatic steatosis","volume":"58","author":"Yozgat","year":"2021","journal-title":"Arq Gastroenterol"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13098-021-00741-5","article-title":"Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease","volume":"13","author":"Karami","year":"2021","journal-title":"Diabetol Metab Syndrome"},{"issue":"2","key":"10.1016\/j.athplu.2023.08.001_bib26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jc.2015-3111","article-title":"Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD","volume":"101","author":"Bril","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.athplu.2023.08.001_bib27","article-title":"Correlation of multiple lipid and lipoprotein ratios with nonalcoholic fatty liver disease in patients with newly diagnosed type 2 diabetic mellitus: a retrospective study","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.athplu.2023.08.001_bib28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/hepr.12094","article-title":"Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases","volume":"43","author":"Masaki","year":"2013","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.athplu.2023.08.001_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/0004563219853596","article-title":"The association between lecithin-cholesterol acyltransferase activity and fatty liver index","volume":"56","author":"Janac","year":"2019","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"10.1016\/j.athplu.2023.08.001_bib30","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.00193.2019","article-title":"HDL flux is higher in patients with nonalcoholic fatty liver disease","volume":"317","author":"McCullough","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.athplu.2023.08.001_bib31","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.numecd.2018.06.016","article-title":"The association between subclinical inflammation and abnormal glucose and lipid metabolisms in normal-weight Korean individuals","volume":"28","author":"Kim","year":"2018","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1309\/LMI6I2RN7AMPEUUL","article-title":"Association between C-reactive protein, anthropometric and lipid parameters among healthy normal weight and overweight postmenopausal women in Montenegro","volume":"45","author":"Klisic","year":"2014","journal-title":"Lab Med"},{"issue":"9","key":"10.1016\/j.athplu.2023.08.001_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12648","article-title":"Increased atherogenic lipoprotein profile in children with non-alcoholic steatohepatitis","volume":"15","author":"Castillo-Leon","year":"2020","journal-title":"Pediatr Obes"},{"issue":"6","key":"10.1016\/j.athplu.2023.08.001_bib34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.aohep.2019.07.006","article-title":"Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis","volume":"18","author":"Loaeza-Del Castillo","year":"2019","journal-title":"Ann Hepatol"},{"issue":"12","key":"10.1016\/j.athplu.2023.08.001_bib35","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/gut.2005.079814","article-title":"Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis","volume":"55","author":"Allocca","year":"2006","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.athplu.2023.08.001_bib36","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.3390\/jcm9113522","article-title":"Associations of HDL subspecies defined by ApoC3 with non-alcoholic fatty liver disease: the multi-ethnic study of atherosclerosis","volume":"9","author":"Morze","year":"2020","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.athplu.2023.08.001_bib37","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/pedi.13103","article-title":"Effects of fatty liver on the size and composition of high-density lipoprotein cholesterol subpopulations in adolescents with type 2 diabetes mellitus","volume":"21","author":"Orozco Morales","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12876-021-01958-4","article-title":"Correlation between HDL2, HDL3 and serum ferritin levels with fatty liver and NAFLD activity score (NAS) in liver histology of organ donors","volume":"21","author":"Nikeghbalian","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"10.1016\/j.athplu.2023.08.001_bib39","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.3390\/ijms23126786","article-title":"Lipidomic approaches to study HDL metabolism in patients with central obesity diagnosed with metabolic syndrome","volume":"23","author":"Mocciaro","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.athplu.2023.08.001_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/metabo10040163","article-title":"A review of lipidomics of cardiovascular disease highlights the importance of isolating lipoproteins","volume":"10","author":"Ding","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.athplu.2023.08.001_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101728","article-title":"Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)","volume":"73","author":"Mocciaro","year":"2023","journal-title":"Mol Metabol"},{"key":"10.1016\/j.athplu.2023.08.001_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12014-018-9186-0","article-title":"Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease","volume":"15","author":"Rao","year":"2018","journal-title":"Clin Proteonomics"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.P088997","article-title":"Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol","volume":"60","author":"van den Berg","year":"2019","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgac565","article-title":"Differences in HDL-bound apolipoproteins in patients with advanced liver fibrosis due to nonalcoholic fatty liver disease","volume":"108","author":"Bril","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.athplu.2023.08.001_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.athplu.2023.08.001_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2018.07.028","article-title":"Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease","volume":"277","author":"van den Berg","year":"2018","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.athplu.2023.08.001_bib47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/biomedicines8120625","article-title":"HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically- but not genetically driven non-alcoholic fatty liver disease (NAFLD)","volume":"8","author":"Di Costanzo","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29639-5","article-title":"Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis","volume":"8","author":"Fadaei","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib49","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2119\/molmed.2012.00113","article-title":"Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice","volume":"18","author":"Karavia","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.athplu.2023.08.001_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2015.09.040","article-title":"Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition","volume":"766","author":"Karavia","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2006.02.037","article-title":"Altered hepatic lipid status and apolipoprotein A-I metabolism in mice lacking phospholipid transfer protein","volume":"190","author":"Siggins","year":"2007","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.athplu.2023.08.001_bib52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/72869","article-title":"Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice","volume":"24","author":"Ors\u00f3","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.athplu.2023.08.001_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biochi.2014.04.010","article-title":"ApoA-I or ABCA1 expression suppresses fatty acid synthesis by reducing 27-hydroxycholesterol levels","volume":"103","author":"Ma","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.athplu.2023.08.001_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108564","article-title":"SR-BI deficiency disassociates obesity from hepatic steatosis and glucose intolerance development in high fat diet-fed mice","volume":"89","author":"Hoekstra","year":"2021","journal-title":"J Nutr Biochem"},{"issue":"36","key":"10.1016\/j.athplu.2023.08.001_bib55","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1021\/acs.biochem.5b00700","article-title":"Scavenger receptor class B type I regulates plasma apolipoprotein E levels and dietary lipid deposition to the liver","volume":"54","author":"Karavia","year":"2015","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.athplu.2023.08.001_bib56","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1172\/JCI115993","article-title":"Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences","volume":"90","author":"Jiang","year":"1992","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.athplu.2023.08.001_bib57","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bcp.2012.06.020","article-title":"Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice","volume":"84","author":"Li","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.athplu.2023.08.001_bib58","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/hep.27985","article-title":"Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells","volume":"62","author":"Wang","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.athplu.2023.08.001_bib59","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.0000260202.79927.4f","article-title":"Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice","volume":"100","author":"Van Eck","year":"2007","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbalip.2008.12.008","article-title":"PXR agonism decreases plasma HDL levels in ApoE3-Leiden.CETP mice","volume":"1791","author":"de Haan","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.athplu.2023.08.001_bib61","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.2337\/db18-0474","article-title":"CETP inhibition improves HDL function but leads to fatty liver and insulin resistance in CETP-expressing transgenic mice on a high-fat diet","volume":"67","author":"Zhu","year":"2018","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehu319","article-title":"Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin","volume":"36","author":"K\u00fchnast","year":"2015","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.athplu.2023.08.001_bib63","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1111\/liv.14643","article-title":"Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative","volume":"40","author":"Stokman","year":"2020","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.athplu.2023.08.001_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.athplu.2023.08.001_bib65","article-title":"Scavenger receptor class B, type 1 facilitates cellular fatty acid uptake","volume":"1865","author":"Wang","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2004.04.097","article-title":"Scavenger receptor class B, type I mediates uptake of lipoprotein-associated phosphatidylcholine by primary porcine cerebrovascular endothelial cells","volume":"368","author":"Sovic","year":"2004","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12944-017-0497-3","article-title":"Overexpression of apolipoprotein A-I alleviates endoplasmic reticulum stress in hepatocytes","volume":"16","author":"Guo","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2018.03.003","article-title":"Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C \u03b4 pathway","volume":"498","author":"Liang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.athplu.2023.08.001_bib69","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.jacl.2018.08.003","article-title":"Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled study","volume":"12","author":"Oscarsson","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"6","key":"10.1016\/j.athplu.2023.08.001_bib70","article-title":"Zebrafish as outgroup model to study evolution of scavenger receptor class B type I functions","volume":"1868","author":"Verwilligen","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.athplu.2023.08.001_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2022.02.018","article-title":"Stabilin 1 and 2 are important regulators for cellular uptake of apolipoprotein B-containing lipoproteins in zebrafish","volume":"346","author":"Verwilligen","year":"2022","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.athplu.2023.08.001_bib72","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1194\/jlr.M046540","article-title":"Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia","volume":"55","author":"O'Hare","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.athplu.2023.08.001_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15601","article-title":"Zebrafish facilitate non-alcoholic fatty liver disease research: tools, models and applications","author":"Chang","year":"2023","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.athplu.2023.08.001_bib74","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1210\/jc.2011-1846","article-title":"LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals","volume":"97","author":"Haase","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.athplu.2023.08.001_bib75","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2010.06.024","article-title":"Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors","volume":"54","author":"Syder","year":"2011","journal-title":"J Hepatol"},{"issue":"26","key":"10.1016\/j.athplu.2023.08.001_bib77","doi-asserted-by":"crossref","first-page":"23699","DOI":"10.1074\/jbc.M211233200","article-title":"Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver","volume":"278","author":"Van Eck","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.athplu.2023.08.001_bib78","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clinbiochem.2019.06.014","article-title":"Rare P376L variant in the SR-BI gene associates with HDL dysfunction and risk of cardiovascular disease","volume":"73","author":"Samadi","year":"2019","journal-title":"Clin Biochem"},{"issue":"6278","key":"10.1016\/j.athplu.2023.08.001_bib79","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"CARDIoGRAM Exome Consortium; Global Lipids Genetics Consortium. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.athplu.2023.08.001_bib80","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1124\/mol.115.099598","article-title":"Marketed drugs can inhibit cytochrome P450 27A1, a potential new target for breast cancer adjuvant therapy","volume":"88","author":"Mast","year":"2015","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.athplu.2023.08.001_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.700","article-title":"Dexmedetomidine ameliorates high-fat diet-induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice","volume":"9","author":"Tao","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.athplu.2023.08.001_bib82","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/NSS.S262991","article-title":"Feasibility of patient-controlled sleep with dexmedetomidine in treating chronic intractable insomnia","volume":"12","author":"An","year":"2020","journal-title":"Nat Sci Sleep"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089523000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089523000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:43:54Z","timestamp":1763023434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667089523000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":82,"alternative-id":["S2667089523000366"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2023.08.001","relation":{},"ISSN":["2667-0895"],"issn-type":[{"value":"2667-0895","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density lipoproteins and non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2023.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}